Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma
Hui Yan, Bo Zhai, Fang Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions
Hossein Omidian, Kwadwo Mfoafo
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1583-1583
Open Access | Times Cited: 18
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 17
Hydride-reduction-induced oxygen vacancies in CoV2O6 for machine learning-assisted enhanced electrochemical detection of homovanillic acid
Sana Jawaid, Razium Ali Soomro, Selcan Karakuş, et al.
Journal of Materials Science Materials in Electronics (2025) Vol. 36, Iss. 3
Open Access
Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets
Santharam S. Katta, Veerababu Nagati, Atreya S.V. Paturi, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 444-459
Closed Access | Times Cited: 14
Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies
Cátia Domingues, Ivana Jarak, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2431-2431
Open Access | Times Cited: 14
Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2825-2825
Open Access | Times Cited: 19
Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2174-2174
Open Access | Times Cited: 11
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
Zhen Liu, Xiaoyang Wang, Han-Wei Wang, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
Xuejia Kang, Nur Mita, Lang Zhou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1228-1228
Open Access | Times Cited: 1
EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness
Simona Cocchi, Valentina Greco, Viktoryia Sidarovich, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4795-4795
Open Access
Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
Zhen Liu, X. Wang, Han-Wei Wang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top